This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.
Here is a sample of this item:
by Stockwatch Business Reporter
The S&P/TSX Cannabis Index lost 3.85 points to 145.17 Wednesday, while the Canadian Securities Exchange Composite Index gained 0.19 point to 362.68. Florida-based cannabis producer Trulieve Cannabis Corp. (TRUL) lost 73 cents to $17.82 on 570,600 shares after releasing its first quarter results. Trulieve had adjusted EBITDA of $49.4-million (U.S.) on net revenue of $96-million (U.S.) in Q1 2020, compared with adjusted EBITDA of $45-million (U.S.) on net revenue of $79.7-million (U.S.) in Q4 2019.
Trulieve continues to increase its revenue despite its presence being mostly limited to Florida, where medical cannabis is legal but recreational cannabis is not. Forty-seven of Trulieve's 49 dispensaries are in Florida. The other two dispensaries are in California and Connecticut, and the company plans to expand further outside of Florida in 2020.
In Q1, Trulieve had net income of $13.9-million (U.S.) despite a $4.4-million (U.S.) downward accounting adjustment. The company also had cash flow from operating activities of $24.5-million (U.S.). The stock closed down today, but Trulieve is up nicely to $17.82 from $13.27 one month ago.
The remainder is available to Stockwatch subscribers.
© 2020 Canjex Publishing Ltd. All rights reserved.